Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | The impact of hemophilia inhibitors on patient outcomes

Melissa Bou Jaoudeh, PhD, Sorbonne University, Paris, France, highlights some of the challenges in the management of patients with hemophilia with inhibitors, discussing the influence of bypassing agents on artieral and venous thrombotic events, and emphasizing the importance of eradicating inhibitors in this patient population. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK